Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
2016 1
2018 4
2019 6
2020 12
2021 20
2022 24
2023 22
2024 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy.
Falagario UG, Abbadi A, Remmers S, Björnebo L, Bogdanovic D, Martini A, Valdman A, Carrieri G, Menon M, Akre O, Eklund M, Nordström T, Grönberg H, Lantz A, Wiklund P. Falagario UG, et al. Among authors: remmers s. JAMA Netw Open. 2023 Sep 5;6(9):e2332900. doi: 10.1001/jamanetworkopen.2023.32900. JAMA Netw Open. 2023. PMID: 37695584 Free PMC article.
Reply by Authors.
Meijer D, Luiting HB, van Leeuwen PJ, Remmers S, Jansen BHE, Bodar YJL, Witteveen T, Schaake EE, van der Poel HG, Wondergem M, Busstra MB, Nieuwenhuijzen JA, Meijnen P, Brabander T, van Moorselaar RJA, Hendrikse NH, Oprea-Lager DE, Roobol MJ, Vis AN. Meijer D, et al. Among authors: remmers s. J Urol. 2021 Apr;205(4):1108-1109. doi: 10.1097/JU.0000000000001437.02. Epub 2021 Jan 25. J Urol. 2021. PMID: 33493004 No abstract available.
A Detailed Evaluation of the Effect of Prostate-specific Antigen-based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer.
de Vos II, Meertens A, Hogenhout R, Remmers S, Roobol MJ; ERSPC Rotterdam Study Group. de Vos II, et al. Among authors: remmers s. Eur Urol. 2023 Oct;84(4):426-434. doi: 10.1016/j.eururo.2023.03.016. Epub 2023 Apr 5. Eur Urol. 2023. PMID: 37029074 Free article. Clinical Trial.
Reply by Authors.
Luiting HB, van Leeuwen PJ, Remmers S, Donswijk M, Busstra MB, Bakker IL, Brabander T, Stokkel M, van der Poel HG, Roobol MJ. Luiting HB, et al. Among authors: remmers s. J Urol. 2020 Sep;204(3):510. doi: 10.1097/JU.0000000000001012.02. Epub 2020 Jun 26. J Urol. 2020. PMID: 32589489 No abstract available.
Reply to Borivoj Golijanin, Anthony Mega, and Dragan Golijanin's Letter to the Editor re: Ivo I. de Vos, Sebastiaan Remmers, Renée Hogenhout, Monique J. Roobol, ERSPC Rotterdam Study Group. Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam. Eur Urol 2024;85:74-81.
de Vos II, Remmers S, Roobol MJ. de Vos II, et al. Among authors: remmers s. Eur Urol. 2024 May;85(5):e142. doi: 10.1016/j.eururo.2024.01.020. Epub 2024 Feb 18. Eur Urol. 2024. PMID: 38369420 No abstract available.
Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer.
Remmers S, Bangma CH, Godtman RA, Carlsson SV, Auvinen A, Tammela TLJ, Denis LJ, Nelen V, Villers A, Rebillard X, Kwiatkowski M, Recker F, Wyler S, Zappa M, Puliti D, Gorini G, Paez A, Lujan M, Nieboer D, Schröder FH, Roobol MJ. Remmers S, et al. Eur Urol. 2023 Nov;84(5):503-509. doi: 10.1016/j.eururo.2023.03.031. Epub 2023 Apr 21. Eur Urol. 2023. PMID: 37088597 Free PMC article. Clinical Trial.
Prostate Cancer Early Detection in the European Union and UK.
Leenen RCA, Venderbos LDF, Helleman J, Gómez Rivas J, Vynckier P, Annemans L, Chloupková R, Májek O, Briers E, Vasilyeva V, Remmers S, van Harten MJ, Denijs FB, de Vos II, Chandran A, Basu P, van den Bergh RCN, Collen S, Van Poppel H, Roobol MJ, Beyer K; PRAISE-U Consortium. Leenen RCA, et al. Among authors: remmers s. Eur Urol. 2024 Aug 24:S0302-2838(24)02502-8. doi: 10.1016/j.eururo.2024.07.019. Online ahead of print. Eur Urol. 2024. PMID: 39183092 Free article. Review.
Unanswered questions in prostate cancer - findings of an international multi-stakeholder consensus by the PIONEER consortium.
Omar MI, MacLennan S, Ribal MJ, Roobol MJ, Dimitropoulos K, van den Broeck T, MacLennan SJ, Axelsson SE, Gandaglia G, Willemse PP, Mastris K, Ransohoff JB, Devecseri Z, Abbott T, De Meulder B, Bjartell A, Asiimwe A, N'Dow J; PIONEER Consortium. Omar MI, et al. Nat Rev Urol. 2023 Aug;20(8):494-501. doi: 10.1038/s41585-023-00748-9. Epub 2023 Apr 3. Nat Rev Urol. 2023. PMID: 37012441 Review.
Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling.
Van Hemelryk A, Tomljanovic I, de Ridder CMA, Stuurman DC, Teubel WJ, Erkens-Schulze S, Verhoef EI, Remmers S, Mahes AJ, van Leenders GJLH, van Royen ME, van de Werken HJG, Grudniewska M, Jenster GW, van Weerden WM. Van Hemelryk A, et al. Among authors: remmers s. Cells. 2022 Nov 16;11(22):3632. doi: 10.3390/cells11223632. Cells. 2022. PMID: 36429059 Free PMC article.
91 results